Introduction
Bovine papillomavirus type 4 (BPV-4) infects the mucosal epithelium of the alimentary canal of cattle and causes papillomas, which can progress to cancer in animals that feed on bracken fern (Campo et al., 1994) . BPV-4 is incapable of transforming bovine primary ®broblasts derived from the foetal palate (PalFs), requiring, instead, cooperation with an activated ras gene. These partially transformed PalFs have an extended proliferative life-span, are capable of anchorage-independent (AI) growth but are not tumorigenic in athymic mice (Jaggar et al., 1990) .
The transforming genes of BPV-4 are the E7 and E8 open reading frames (ORFs). The E7 ORF encodes a polypeptide with sequence similarities to the E7 proteins of high risk human papillomaviruses type 16 and 18, which have been shown to inactivate the pRb tumour suppressor protein, and to interact with a variety of cellular proteins including transcription factors and key components of the basal transcription machinery (Jackson et al., 1996) . The E8 ORF encodes a small (42 residue) polypeptide that bears some resemblance to the E5 oncoprotein of BPV-1: both are localized to cellular membranes and have two distinct domains: a hydrophobic membrane domain (residues 1 ± 30) with the capacity to form an a-helix and a hydrophilic`tail' region (residues 31 ± 42, E8; 31 ± 44, E5) which is not thought to be membrane localized (Jackson et al., 1996) . BPV-1 E5 can transform established mouse ®broblasts (Settleman et al., 1989) and keratinocytes (Leptak et al., 1991) . The transforming function of E5 is attributed to its ability to activate growth factor receptors (Martin et al., 1989; Goldstein et al., 1994) and to complex with 16 kDa ductin, a component of both the vacuolar ATPase and gap junctions (Goldstein et al., 1991) . It has been suggested that E5 acts to potentiate mitogenic signals from growth factors and to reduce homeostatic control on virally infected cells exerted by surrounding normal cells (Jackson et al., 1996) . E8 can also bind ductin in vitro and block gap-junction communication (GJIC) in PalF cells, suggesting that this attenuation of GJIC results from the ductin-E8 interaction (Faccini et al., 1996) . It is not yet known if E8 can interact with growth factor receptors to promote their activation. E8 also contributes to cell transformation by allowing cells to proliferate in suspension (Pennie et al., 1993) , demonstrating that it over-rides the control mechanisms that arrest anchorage-dependent cells in late G1 phase of the cell cycle when maintained in suspension (Guadagno and Assoian, 1991) .
Progression through the cell cycle in mammalian cells, including anchorage-dependent passage through G1 (Guadagno and Assoian, 1991) , is controlled by the co-ordinate activation of cyclin-dependent kinases (Cdks). Cdk activity is regulated at multiple levels including the phosphorylation of speci®c residues that activate or inhibit the kinase and the availability of cognate cyclins, the expression of which is strictly regulated in normal cells. D-type cyclins are required for progression through early/mid G1 phase of the cell cycle and in the decision to embark on a new cell cycle or to enter a quiescent state (GO) after mitosis, linking cell exposure to external cues to entry into the cell cycle (Won et al., 1992; Baldin et al., 1993) . Cyclin E is expressed in late G1 and is required for entry into Sphase in mammalian ®broblasts (Resnitzky et al., 1994; Ohtsubo et al., 1995) , while Cyclin A is ®rst expressed at the G1/S transition (Henglein et al., 1994) and is required, in complex with cdk2, for the completion of S-phase and, in complex with cdc2, for passage through G2 and mitosis (Girard et al., 1991; Pagano et al., 1992) .
Another level of control of cyclin-cdk complexes is via a strong inhibition of activity by two families of small proteins: the INK family, p15, p16, p18, p19 which target cdk4/cdk6 and prevent cyclin binding and members of the KIP/CIP family composed of p21, p27 and p57, which target cyclin A-and E-cdk2 complexes (Sherr and Roberts, 1995) .
Cyclin A gene expression is regulated at the level of transcriptional initiation with expression being repressed in G1 and strongly induced as cells enter Sphase (Henglein et al., 1994) . Cyclin E-cdk2 activity is required for elevated cyclin A expression in NIH3T3 cells (Zerfass-Thome et al., 1997) . Cyclin A expression is down-regulated in NIH3T3 cells maintained in suspension or in low serum culture conditions; under these conditions p27
Kip1 is elevated and blocks cyclin Ecdk2 mediated de-repression of the cyclin A promoter (Zerfass- Thome et al., 1997) .
The intracellular concentration of p27 Kip1 is a major determinant of cell cycle progression through the G1 restriction point (Coats et al., 1996) and has emerged as a key target for viral oncoproteins. Both human Adenovirus E1A and HPV-16 E7 proteins can inactivate p27
Kip1 by forming complexes which render p27
Kip1 non-functional in vitro and in vivo (Mal et al., 1996; Zerfass-Thome et al., 1997 ). Here we have tested whether E8 may also inhibit p27
Kip1 function contributing to cell transformation. We have expressed E8 in isolation from other BPV-4 genes in NIH3T3 cells and determined cyclin A gene promoter activity and cyclin A-associated kinase activity as measures of p27 Kip1 functional status (Zerfass-Thome et al., 1997) .
We show, for the ®rst time, that E8 on its own is transforming. Cells expressing E8 grow in suspension and continue to proliferate when serum is removed. E8 expression induces transcription from a heterologous (human) Cyclin A promoter indicating that homologous promoter activation may be involved in the increase in cyclin A protein levels observed in suspension and low serum culture conditions. Cyclin A-associated, but not cyclin E-associate kinase activity is sustained in E8-3T3 cells in LS. Increased cyclin Aassociated kinase activity is observed despite elevated levels of p27 Kip1 . Analysis of E8 mutants indicate that the hydrophilic tail' of the molecule (residues 31 ± 42) is required for cell transformation and that the location of E8 within cellular membrane compartments appears crucial for cell transformation.
Results
Cells expressing E8 are morphologically transformed and are capable of anchorage-independent growth E8 expression in transfectants was determined by reverse-transcriptase polymerase chain reaction (RT ± PCR) to detect mRNA (results not shown). Cells expressing E8 (E8-3T3) are morphologically transformed, appearing more rounded and refractile ( Figure 1c ) than parental NIH3T3 cells (Figure 1a ) or control cells (Figure 1b) transfected with the empty expression vector.
We have demonstrated previously that the E8 ORF can confer AI growth on primary bovine ®broblasts co-expressing BPV-4 E7 and an activated ras gene (Pennie et al., 1993) . We found that E8-3T3 cells were also capable of AI growth (Figure 2a ) with an eciency of colony formation (diameter 40.1 mm) approximately 3.5 times that of parental or control cells ( Figure 2b) ; large (40.25 mm) colonies were found only in cells expressing E8.
Cells expressing E8 continue to proliferate in low serum (LS) but do not appear to activate an autocrine mechanism Transfectants and parental NIH3T3 cells had very similar population growth kinetics and cell-cycle pro®les when maintained in normal growth medium (GM) containing 10% serum (results not shown). To test if growth dierences were manifest under LS conditions, cells were maintained in LS for 48 h then harvested and analysed for cell cycle distribution by propidium iodide staining and¯ow cytometry. Control transfectants were growth arrested with no more than 10% of the cells in S-phase ( Figure 3a) ; a similar pro®le was seen with parental cells with 5 ± 8% of the cells in S-phase (results not shown). E8-3T3 cells however, had a high proportion (approximately 20%) of cells in S-phase (Figure 3a) . We extended this analysis to cover population growth over a 6 day period in LS. As shown in Figure 3b , E8-3T3 cells continued to proliferate, while there was little or no growth in the control population. Proliferation in LS could be explained if E8-3T3 cells secreted a mitogen(s) and so stimulated their own cell cycle progression, but conditioned medium from E8-3T3 cells did not stimulate proliferation of parental or control cells (results not shown) suggesting that E8 did not prevent cell cycle exit in LS by activating an autocrine mechanism. Together these data show that E8-3T3 cells are morphologically transformed, capable of AI growth and continue to proliferate in the absence of serum mitogens.
Cyclin A promoter activity as a measure of p27
Kip1 functional status
During the cell cycle, cyclin A gene expression is strictly regulated at the level of transcription (Henglein et al., 1994) and cyclin A-associated kinase activity is rate limiting for entry of mammalian ®broblasts into S-phase (Resnitzky et al., 1994) . Also, normal cells maintained in low serum (Firpo et al., 1994) or in suspension (Guadagno et al., 1993; Fang et al., 1996) do not express cyclin A and cannot progress into S-phase. Constitutive expression of cyclin A, but not cyclins D1 or E, allows NRK ®broblasts to proliferate in suspension (Guadagno et al., 1993) , while induction of cyclin A expression can promote premature entry into S-phase of ®broblasts made quiescent by serum withdrawal (Resnitzky et al., Figure 2 Cells expressing wild-type E8 are capable of anchorageindependent growth in soft agar culture. (a) Phase-contrast images of colonies from transfectants maintained in suspension culture for 21 days. Cells transfected with the empty expression vector (pZipneo; Ctrl), an E8 expression vector (pZipneoE8; E8wt) and an expression vector containing a mutant form of E8 representing the ®rst 30 N-terminal residues (pZipneoE8N1-30). (Final magni®cation; 620). (b) Quantitation of soft agar colony formation in transfectants. After 21 days in suspension culture, colony formation was scored by estimating the total number of colonies with a diameter greater than 0.1 mm present in triplicate wells for each cell type. The number of colonies was expressed as a percentage of the total number of cells seeded into each well (5000) on day 0. Bar=standard deviation Figure 3 Growth characteristics of cells maintained in LS (DMEM, containing 0.5% CS). (a) Flow cytometry analysis of independent clones expressing E8 (E8.6, E8.7) or transfected with the empty expression vector (V1, V2). The percentage of cells remaining in S-phase after 48 h in LS was determined by¯ow cytometry as described in Materials and methods. (b) Only cells expressing E8 continued to proliferate in LS. Growth curves for NIH3T3 (Parent), control transfectants (V1, V2) and E8-3T3 clones (E8.6, E8.8) maintained in LS for 6 days. Cell growth was determined by MTT dye reduction and is expressed as a growth index representing the fold change in cell population from the day 1 (harvested 5 h after seeding the cells) BPV-4 E8 de-regulates cell-cycle control V O'Brien and M Saveria Campo 1994). We measured cyclin A promoter activity in our cell lines to determine if cyclin A expression was deregulated as a consequence of E8 expression which, in turn, might suggest that p27 Kip1 function was blocked. Cells were co-transfected with a luciferase reporter gene under transcriptional control of the human cyclin A promoter (Kramer et al., 1996) . Under normal growth conditions (adherent culture in GM) E8 expression led to at least a sixfold increase in cyclin A promoter activity in two independent clones ( Figure 4a ) compared with control cells. Promoter activity remained relatively high when these cells were maintained both in LS ( Figure 4a ) and in suspension culture ( Figure 4b ) conditions imposed for the 24 h period following transfection. The dierences in cyclin A promoter activity between control and E8-3T3 cells were not due to dierences in transfection eciencies as both lines were transfected to the same extent as assessed using an expression plasmid for bgalactosidase and in situ staining for this enzyme activity (results not shown). Moreover, similar results were seen in transient transfection experiments in which the cyclin A reporter plasmid was co-transfected with an E8 expression plasmid in both NIH3T3 cells and in primary bovine ®broblasts derived from the foetal palate (O'Brien et al., manuscript in preparation). We conclude that E8 can de-regulate expression of the cyclin A gene in ®broblasts perhaps by inactivating p27 Kip1 .
Alterations in cyclin A and cyclin A-associated kinase activity and total cdk2 kinase activity in cells expressing E8
As shown above, E8 can promote transcriptional activation of a heterologous cyclin A promoter and so we examined whether levels of cyclin A protein were elevated in E8-3T3 cells, re¯ecting transcriptional activation of the homologous promoter. In both GM and after 48 h in LS, the level of cyclin A was signi®cantly elevated in E8-3T3 cells compared to control cells (Figure 5a ). This de-regulation of cyclin A expression was also observed in pooled transfectants maintained in GM in adherent conditions or after 72 h in LS (Figure 5b ). Cyclin A levels remained relatively high in pooled E8-3T3 cells after 24 h in suspension culture, while this protein was not detected, or present at only very low levels, in parental and control cells under the same culture conditions (Figure 5b ). These results are consistent with transcriptional activation of the homologous cyclin A promoter in E8-3T3 cells. There were no dierences in expression patterns for cyclins D1 or E between E8-3T3 and control cells (results not shown).
To test if the increased levels of cyclin A in E8-3T3 cells were accompanied by an increase in cyclin Aassociated kinase activity, cyclin A-associated complexes were immunoprecipitated from lysates of control and E8-3T3 cells, using an antibody to cyclin A, and the associated kinase activity was assayed with histone H1 as substrate. Indeed, a higher level of cyclin Aassociated kinase activity was observed in E8-3T3 cells compared with control cells kept in GM (Figure 6a ). However, little or no dierence was observed in cyclin E-cdk2 activity under these growth conditions ( Figure  6a ). As expected, cyclin A-and cyclin E-associated kinase activities were diminished signi®cantly by withdrawal of serum mitogens from control cells for 24 h. In contrast, E8-3T3 cells displayed a sustained cyclin A-associated kinase activity following serum withdrawal, while cyclin E-cdk2 activity was downregulated in these cells (Figure 6a ). Signi®cant cyclin A-associated and total cdk2 kinase activities can still be detected in lysates from E8-3T3 cells maintained in LS for 72 h (Figure 6b ).
These results demonstrate that E8 expression leads to up-regulation, not only of cyclin A protein levels, but also of its associated kinase activities (cdk2 and cdc2) and these kinase activities are sustained in E8- Figure 4 Transactivation of the human cyclin A promoter in E8-3T3 cells. The transcriptional activity of the cyclin A promoter was determined after transfection of the reporter plasmid pwt929 into independent clones derived from cells transfected with pcDNA3 vector (V1) or pcDNA3-E8 (E8.6, E8.7). The fold induction in luciferase activity is given after normalization of cellular protein content and, in each case, mean values from duplicate samples are given for a representative experiment. (a) E8 permits sustained transcriptional activation of the cyclin A promoter after 24 h in LS. Cells were transfected with the cyclin A reporter plasmid (pwt929) and 16 h later washed with PBS and kept in either GM (10% serum) or LS (0.5% serum) for a further 24 h before harvesting and measurement of luciferase activity. (b) Promoter activation is maintained in E8 cells in suspension culture. Cells were transfected and harvested by trypsinization 16 h later then re-seeded in GM into tissue-culture grade dishes (adherent culture, Adh) or in GM containing 0.75% methocel into Petri dishes (suspension culture, Susp) for 24 h before harvesting and determination of luciferase activity 3T3 cells deprived of serum mitogens. In contrast, E8 does not alter expression of cyclin E or regulation of its associated kinase activity by serum mitogens.
E8 de-regulates p27
Kip1 expression
The results so far demonstrate that E8 expression allowed S-phase entry of NIH3T3 cells under conditions in which control cells were made quiescent by serum withdrawal or were arrested in G1 by suspension culture. These are two experimental conditions in which it has been shown that levels of the cdk inhibitor p27 Kip1 are elevated (Pagano et al., 1992) . Thus E8 may operate by impairing the ability of p27
Kip1 to block cdk activity and cell cycle progression either by inhibiting gene transcription, promoting protein degradation or by inhibiting p27
Kip1 function. Levels of p27
Kip1 were elevated in parental and control cells after serum withdrawal, while they were signi®cantly reduced in cells re-stimulated with 10% serum addition after 72 h in LS (Figure 5c and d) . In contrast, E8-3T3 cells expressed high levels of p27
Kip1 under all culture conditions tested, including LS and suspension (Figure 5c ) ± conditions under which E8-3T3 cells continued to proliferate (see Figures 2 and 3 ). The results demonstrate that the regulation of p27 Kip1 expression is disrupted by E8 and suggest that p27
Kip1 is non-functional in cells expressing E8 as elevated levels of p27
Kip1 do not correlate with cell cycle arrest or with inhibition of cyclin A-associated kinase activity following serum withdrawal.
Mutants forms of E8
As mentioned in the introduction, structurally E8 can be divided into two domains: the ®rst 30 amino acid residues are hydrophobic, may adopt an a-helical conformation, and are thought to be membrane localized, while the C-terminal 12 amino acid residues are generally hydrophilic and are not thought to be membrane localized. A mutant form of E8, comprising only the ®rst 30 amino acid residues was produced to determine if the membrane domain was sucient to transform NIH3T3 cells. Cells expressing E8N1-30 displayed an altered phenotype from control cells: they were much more adherent to substratum as assessed by relative resistance to removal by trypsinization (V Figure 5 Expression of cyclin A is elevated and p27 Kip1 expression is de-regulated in E8-3T3 cells. Whole cell extracts (50 ± 100 mg cellular protein) were prepared and fractionated by SDS ± PAGE, transferred to a nitrocellulose membrane and probed for cyclin A or p27
Kip1 expression by immunoblotting. (a) Cyclin A expression is not down-regulated in E8-3T3 cells after 48 h in LS. Extracts (50 mg protein) were prepared from clonal NIH3T3 lines expressing E8 (E8.6, E8.7) or transfected with the empty expression vector (V1, V2) and maintained in GM (H) or in LS (L) for 48 h. Immunoblotting was performed using an antibody to cyclin A (C19; Santa Cruz Biotechnology) and ECL detection system (Amersham). (b) Cyclin A protein is elevated in pooled E8-3T3 cells after 72 h in LS. Cell extracts (50 mg protein) were prepared from cells maintained in LS for 72 h, or released from LS into GM for 24 h in suspension culture or normal adherent culture conditions. Cyclin A protein was detected as described in (a). Two immunoreactive bands were detected in this series of experiments due to limited proteolysis of cyclin A protein during the extraction procedure. (c) Expression of p27
Kip1 is de-regulated in E8-3T3 cells and remains high under all culture conditions tested. Extracts (100 mg protein) were prepared from cells maintained as described in (b) and p27 Kip1 expression was determined by immunoblotting using a rabbit polyclonal antibody against mouse p27
Kip1 (a kind gift from Dr Steve Coats, Amgen, USA). LS ± cells maintained in LS (0.5% serum) for 72 h; AD ± LS cells released into GM (10% serum) and adherent culture and harvested 24 h later; SN ± LS cells released into GM (10% serum) and suspension culture (0.75% methocel) and harvested 24 h later. (d) E8 mutant4-3T3 and parental NIH3T3 cells have similar patterns of cyclin A and p27 Kip1 expression under all culture conditions tested. (LS, AD, SN; as described above; ASN ± cells growing asynchronously i.e. under normal conditions) Figure 6 Cyclin A-associated kinase activity is up-regulated in E8-3T3 cells and, together with total cdk2 activity, sustained following serum withdrawal. Kinase activity was assayed in cyclin A (a-A), cyclin E (a-E) and cdk2 (a-cdk2) complexes immunoprecipitated (IP) from 500 mg aliquots of lysates and incubated with histone H1 substrate and [g-32 P]ATP. (a) Cyclin A, but not cyclin E-associated kinase activity is sustained in E8-3T3 cells 24 h after switching from GM to medium containing either 0.5% serum (LS) or 0.25% serum. (b) Cyclin A-associated kinase activity and total cdk2 kinase activity is sustained in E8-3T3 cells 72 h after serum withdrawal. Cells were maintained in LS for 72 h then harvested and assayed for cyclin A-, cyclin E-associated kinase activities as well as total cdk2 activity as described in Materials and methods O'Brien, unpublished observations). The reasons for this increased adhesion to substratum are currently under investigation. In transformation assays, E8N1-30 cells were incapable of AI growth (Figure 2a ) and had a similar pattern of cyclin A and p27
Kip1 expression as parental cells under the dierent culture conditions tested (Figure 5d ). Transactivation of the cyclin A promoter was not observed in stable transfectants expressing E8N1-30 and kept in suspension culture (Figure 7a) , suggesting that the hydrophilic`tail' of the E8 molecule is required for cell transformation and activation of cyclin A transcription. A mutant form of E8, in which the C-terminus was extended by six amino acids containing a`KDEL' (SEKDEL) retention signal to restrict distribution to ER and cis-Golgi membrane compartments (Townsley et al., 1993) was produced. This form of E8 was capable of transactivating the cyclin A promoter under normal growth conditions but incapable of transactivating the cyclin A reporter in suspension cells after co-transfection with the reporter plasmid ( Figure 7b ). As a control, a mutant in which the C-terminus was extended by six amino acids which did not contain a valid`KDEL' sequence (SGGGEV) retained its ability to transactivate the cyclin A promoter under adherent and suspension culture conditions (Figure 7b ). Therefore, removal of the 12 residues that constitute the`tail' domain of E8 or restricting expression of the full-length molecule to the ER/cis-Golgi compartments abolishes the ability of E8 to activate cyclin A transcription in suspension culture, which may re¯ect a failure to inactivate p27
Kip1 .
Discussion
We report here, for the ®rst time, that the E8 protein of BPV-4 is capable of transforming NIH3T3 cells in the absence of any other viral or cellular oncogenes. E8 cells exhibit a transformed morphology, do not exit the cell cycle after serum withdrawal and overcome the block in late G1 imposed when anchorage-dependent cells are maintained in suspension. E8 expression can promote transcriptional activation of a heterologous cyclin A promoter and can increase the expression of cylin A protein under conditions where cyclin A expression is normally diminished or is not detectable in control cells. Thus, the normal mechanisms which restrict cyclin A transcription have been lost in cells expressing E8. Also, the activity of the cyclin A-associated kinases is de-regulated in E8-3T3 cells: while these activities are signi®cantly downregulated in control cells following serum withdrawal (Figure 6 ), they are increased in E8-3T3 in GM and sustained for at least 72 h in LS. By contrast, the activity of the cyclin E-cdk2 complex is not signi®cantly altered by E8 expression. We conclude that it is the sustained cyclin A-associated kinase activity which prevents growth arrest of E8-3T3 cells in the absence of serum mitogens. Repression of cyclin A transcription in cells in low serum or suspension culture, has been attributed to p27
Kip1 via its ability to block cyclin E-cdk2 kinase activity which is required for de-repression of the cyclin A promoter through a variant E2F site (Zerfass-Thome et al., 1997) . However, the observation that cyclin E-cdk2 kinase activity is negligible in E8-3T3 cells after serum withdrawal (Figure 6a ), yet cyclin A promoter activity ( Figure 4a ) and endogenous protein levels (Figure 5b) are elevated under the same conditions, point to E8 acting in a dierent way to bring about transcriptional activation of the cyclin A gene, at least in LS conditions. Alternatively, pre-existing, active, cyclin A-cdk2 complexes may substitute for cyclin E-cdk2 activity and act in a positive feedback loop to stimulate cyclin A transcription. Expression of p27
Kip1 is clearly de-regulated in E8-3T3 cells, but the mechanisms by Figure 7 (a) A mutant form of E8 containing only the ®rst 30 Nterminal residues (E8N1-30) cannot transactivate the cyclin A promoter in suspension culture. The transcriptional activity of the cyclin A promoter was determined after transfection of the reporter plasmid pwt929 into cells previously transfected with empty vector (pZipneo plasmid ± pZip cells; pcDNA3 plasmid ± V2 cells) or with an expression vector for wild-type E8 (pcDNA3-E8 plasmid-E8.6 cells) or for E8N1-30 (pZipneoE8N1-30). Cells were harvested by trypsinization 16 h after transfection then reseeded in GM into tissue-culture dishes (adherent culture, Adh) or in GM containing 0.75% methocel into Petri dishes (suspension culture, Susp) for a further 24 h before harvesting and measurement of luciferase activity. The fold induction in luciferase activity is given after normalization on cellular protein content and mean values from duplicate samples are given for a representative experiment. (b) A mutant form of E8 with expression restricted to the Endoplasmic Reticulum (ER)/cisGolgi membrane compartments (E8-KDEL) transactivates the cyclin A promoter in adherent cells but not in suspension cells. Cells were transfected then treated as in described in (a). The fold induction in luciferase activity is given after normalization on cellular protein content and, in each case, mean values from duplicate samples are given for a representative experiment. E8-GGEV : E8 containing a C-terminal hexapeptide as a modi®ed KDEL sequence that does not promote retention in the Endoplasmic Reticulum (see Materials and methods) which E8 achieves this de-regulation are not yet understood. The evidence presented also points to this cdk inhibitor being non-functional in cells expressing E8 i.e. both high levels of p27
Kip1 and cyclin A-associated kinase activity co-exist in E8-3T3 cells.
It has recently been reported that both human Adenovirus E1A and HPV-16 E7 proteins can inactivate p27
Kip1 non-functional in vitro and in vivo (Mal et al., 1996; Zerfass-Thome et al., 1996) . In the case of E1A, the interaction appears direct, at least in vitro, while for E7 the presence of a bridging protein(s) is required for complex formation. Such an interaction is unlikely to occur for E8 as its expression is restricted to cellular membranes and may not be available to interact directly with p27
Kip1 which is located predominantly in the cell nucleus (Reynisdottir and Massague, 1997) . Further experiments are required to formally demonstrate that p27
Kip1 is non-functional in E8-3T3 cells and to determine if inhibition of function is linked to the apparent stabilization of p27
Kip1 in E8-3T3 cells. The results obtained with cells expressing E8N1-30, containing only the putative transmembrane portion of the molecule (residues 1 ± 30), demonstrate that this mutant is incapable of transforming NIH3T3 cells, activating transcription of the cyclin A promoter in adherent or suspension cells or de-regulating expression of cyclin A or p27 Kip1 . This points to the hydrophilic tail' domain of E8 as being important for cell transformation. Alternatively, the remaining membrane domain may adopt an altered, non-functional, conformation or have a dierent cellular distribution to wild-type protein. The data obtained using the E8-KDEL mutant, suggests two things: (i) that a portion of E8 molecules adopts an orientation in which the Cterminus is lumenal in membrane compartments (as the KDEL receptor is located in the lumen) ± this has also been reported for BPV-1 E5 (Burkhardt et al., 1989) ; (ii) the cellular distribution of E8 is crucial for transactivation of cyclin A transcription in suspension culture but not for promoter activation in adherent culture (Figure 6b ). The latter point suggests that restricting E8 expression to ER/cis-Golgi compartments abolishes its ability to transform cells; such restrictive expression has also been shown to prevent cell transformation by BPV-1 E5 oncoprotein (Sparkowski et al., 1995) . We are currently testing whether cells expressing E8-KDEL are transformed.
How this membrane protein, the smallest transforming protein identi®ed to date, achieves its eects will require more detailed studies of its function. The point(s) of action of this molecule is likely to be upstream of the cell cycle regulatory machinery, perhaps acting at the plasma membrane at the convergence of signals from soluble growth factors and adhesion molecules such as integrins. While the precise mechanism of E8 action remains to be determined it is clear that the changes to the cell cycle proteins and activities which are brought about through E8 expression and reported here dier from those observed following growth factor activation or through expression of oncogenes such as ras or myc.
It would also be of interest to establish if expression of E8 inhibits dierentiation of bovine keratinocytes, the natural host cells of BPV-4. Proliferation of these cells is likely to be restricted by TGF-b, a known modulator of p27
Kip1 function (Polyak et al., 1994) . E8 expression may extend the proliferative capacity of host cells by blocking TGF-b mediated inhibition of cell proliferation, through abrogation of p27 Kip1 function, and so promote progression to cancer.
Materials and methods

Plasmids
The expression plasmid for E8 ORF (pZipneoE8) has been described previously (Pennie et al., 1993) and the form of E8 in which a premature stop codon has been introduced at residue 31 (E8N1-30) will be described in O'Brien et al.
(manuscript in preparation). E8-KDEL was made by a Cterminal extension to E8 with a hexapeptide, SEKDEL, containing a`KDEL' signal for retention in the Endoplasmic Reticulum (ER). E8-GGEV contained a C-terminal hexapeptide (SGGGEV) as a modi®ed KDEL sequence that does not promote retention in the ER (Townsley et al., 1993) . E8, E8-KDEL and E8-GGEV were generated by polymerase chain reaction (PCR) with pZipneoE8 as template and using oligonucleotides synthesized on an Applied Biosystems, model 392 automated oligonucleotide synthesizer.
An oligonucleotide (5'-TGCAAGCTTCATCATGTCTTT-GTGGCTTAT-3') corresponding to the 5' end of E8 codes for the ®rst ®ve amino acids of E8 and in addition contains a HindIII site 5' to the translational start site. Three 3' oligonucleotides corresponding to each of the E8 constructs were also synthesized and contained a XbaI site 3' to the translational stop site. They were: (I) E8 (5'-TGCTCT-AGATCAATCCCATCCATCTAACCG-3'), (II) E8-KDEL (5' -TGCTCTAGATCACAACTCGTCCTTCTCAGAATTC-CATCCATCTAA-3') (III) E8-GGEV (5'-TCGTCTAGATC-AAACCTCTCCTCCTCCAGAATCCCATCCATCTAA -3'). All ®nal products were cleaved with HindIII and XbaI and subcloned into the HindII/XbaI sites of an expression vector containing the human cytomegalovirus early enhancer/ promoter sequence (pcDNA3.1; Invitrogen, USA). The ®delity of the recombinant plasmids was veri®ed by automated sequencing.
Cell culture and stable transfection NIH3T3 cells were routinely cultured in Dulbecco's modi®ed Eagle's medium (DMEM) containing 10% newborn calf serum (growth medium; GM). Cells were subcultured at appropriate intervals to maintain sub-con¯uent monolayers. Detachment and dispersion of cells was achieved by a brief exposure to a solution of 0.25% trypsin, 0.02% EDTA in PBS.
For stable transfection, 0.5610 6 cells in 10 ml of GM were seeded 16 ± 18 h prior to transfection with 5 mg of pZipneoE8 or pcDNA3-E8 expression plasmids using the standard calcium phosphate method. For selection of stable transfectants, cells were maintained in GM containing 0.5 mg/ml G418. Pooled transfectants were obtained from G418 resistant colonies about 4 ± 5 weeks after transfection with pZipneo plasmids, while for pcDNA3 and pcDNA3-E8 transfectants individual clones were picked using steel cloning cylinders. All transfectants were routinely maintained in GM supplemented with 0.5 mg/ml G418.
Soft agar colony formation
For analysis of colony formation, 10 000 cells in 4 ml GM containing 0.35% agar were seeded in each well of 6 well plates containing an underlay of 1 ml 0.7% agar in GM. Cultures were supplemented with 2 ml GM per week and BPV-4 E8 de-regulates cell-cycle control V O'Brien and M Saveria Campo colonies (with a diameter 40.1 mm) were scored 21 days after seeding the cells.
Light microscopy
Cells were photographed under phase contrast using a Diaphot-TMD microscope.
Determination of cell population growth in culture
Cell proliferation was measured using MTT reduction in a 96 well tissue culture plate assay (Carmichael et al., 1987) . Cells were seeded at 5000/well in 200 ml of GM. At the indicated time points, 20 ml of a 5 mg/ml solution of MTT in DMEM was added to each well. After 3 h at 378C the medium was aspirated from the wells and 100 ml/well of DMSO was added. After vigorous shaking for 10 min at room temperature, the absorbance of the solubilized dye was determined at 590 nm using an automated microplate reader (Dynatech MR7000). Sample blanks contained medium only. Dye absorbance was linear for 5000 ± 200 000 cells/well in each assay (data not shown).
Flow cytometry
Two million cells were transferred to a 15 ml conical tube and washed twice with ice-cold PBS, resuspended in 0.5 ml PBS and ®xed by the dropwise addition, while gently vortexing, of 2 ml of cold (7208C) absolute ethanol and held on ice for a minimum of 4 h. After ®xation the cells were washed in ice-cold PBS and resuspended in 0.5 ml of staining solution (20 mg/ml propidium iodide, 250 mg/ml DNase-free RNase A in PBS). After 2 h in staining solution, cell¯uorescence was measured on a Becton Dickinson FACScan. DNA histograms were generated from 20 000 events (cells) and analysed for cell cycle distribution using Mod-Fit LT software (Becton Dickinson).
Suspension culture
5610
6 cells in 30 ml of GM were seeded into 150 mm tissue culture dishes and allowed to adhere. After 4 h cells were switched to LS conditions (DMEM containing 0.5% serum) for 72 h. After this time cells were trypsinized and re-seeded, 2610 6 cells in 30 ml. GM in fresh 150 mm tissue culture dishes (adherent cells) or into Petri dishes coated with an underlay of 0.9% agarose in GM (suspension culture). At the indicated times cells were collected and protein lysates prepared for immunoblotting as described below.
Luciferase assays
Cells were seeded at 50 000 cells/ml in GM in 6 well plates, 4 ml/well, the day before transfection, and transfection was performed using the standard calcium phosphate method. After 16 h, cells were washed twice with 2 ml PBS and incubated in 5 ml LS or GM for a further 24 h before being harvested and lysed in reporter lysis buer (Promega; 300 ml per well) and clari®ed by centrifugation for 5 min at 13 0006g at room temperature. For suspension culture, cells were harvested by trypsinization and resuspended in GM and re-plated on tissue culture dishes (adherent cells) or resuspended in 0.75% methocel in GM and added to Petri dishes (suspension cells). All cells were harvested 24 h later i.e. approximately 40 h after starting the transaction. Luciferase activity was measured and integrated over a 30 s period using a luminometer with automatic injection (BioOrbit, model 1251). For each sample, 80 ml of lysate and 120 ml of Luciferase assay buer (Promega) were used. Activity was normalized for protein content determined using the BCA assay (Pierce). The reporter plasmid for the promoter for the human cyclin A gene, pwt929, was provided by Dr William Fahl, University of Wisconsin, USA (Kramer et al., 1996) .
Immunoblotting
Cells were lysed in near-boiling SDS ± PAGE sample buer lacking bromophenol blue and dithiothreitol but containing 1 mM sodium orthovanadate, sonicated and clari®ed by centrifugation at 13 0006g for 5 min at 48C. Protein concentration was determined by absorbance measurement at 280 nm. Samples were adjusted to contain 100 mM DTT, 0.02% bromophenol blue and 2 mg/ml protein concentration then held in a boiling water bath for 5 min. Equal amounts of protein (50 ± 100 mg/lane as indicated) were loaded on a 10% SDS-gel, separated by electrophoresis and transferred onto a nitrocellulose membrane (ECL Hybond, Amersham). Membranes were probed with an antibody to cyclin A (C-19; Santa Cruz Biotechnology) and p27
Kip1 antiserum (a gift from Dr Steve Coats, Amgen, USA). Antibody detection was performed using enhanced chemiluminescence (ECL; Amersham).
Cyclin-dependent kinase assay
Cells were washed with ice-cold PBS, drained and lysed with one freeze thaw cycle in a buer containing 1% NP40, 150 mM NaCl, 50 mM HEPES, pH 7.5, 1 mM EDTA, 2.5 mM EGTA, 1 mM NaF, 0.1 mM sodium orthovanadate, 1 mM b-glycerophophate, 1 mM PMSF and 10 mg/ml each of aprotinin, leupeptin and pepstatin A. After thawing on ice, extracts were clari®ed by centrifugation at 13 000 g for 10 min at 48C, and 500 mg aliquots were adjusted to 1 mg/ml protein concentration with lysis buer, and pre-cleared for 1 h at 48C. Speci®c immune complexes were collected by incubation for 1 h at 48C with the appropriate antibody (cyclin A: Serotec MCA1411; cyclin E, M-20 and cdk2, M2 both from Santa Cruz Biotechnology) and 50 ml of a 50% slurry of Protein A-sepharose (which for cyclin A assays was preincubated with rabbit anti-mouse IgG antibody for 1 h at 48C then washed four times in lysis buer). Immune complexes were washed three times in lysis buer and once in kinase buer (50 mM NaCl, 50 mM HEPES, pH 7.5, 1 mM DTT). Pellets were resuspended in kinase buer containing 50 mg/ml histone H1 (Upstate Biotechnology), 10 mM ATP, 10 mCi [g-32 P]ATP (3000 Ci/mmol) and 0.1 mM protein kinase A inhibitor (Sigma, P0300) and incubated at 308C for 30 min. The reaction was stopped by adding 40 ml of SDS ± PAGE loading buer and, following separation of the reaction products by SDS ± PAGE, phosphorylation of histone H1 substrate was monitored by autoradiography.
Abbreviations AI: anchorage-independent growth; BPV-4: Bovine papillomavirus type-4; cdk: cyclin-dependent kinase; CS: newborn calf serum, GJIC: gap-junctional intercellular communication; GM: 10% serum growth medium; LS: 0.5% serum growth medium; ORF: Open Reading Frame.
